These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics. Korošec Hudnik L; Blagus T; Redenšek Trampuž S; Dolžan V; Bon J; Pjevac M Front Psychiatry; 2024; 15():1363051. PubMed ID: 38566958 [TBL] [Abstract][Full Text] [Related]
3. Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic. Müller DJ; Kekin I; Kao AC; Brandl EJ Int Rev Psychiatry; 2013 Oct; 25(5):554-71. PubMed ID: 24151801 [TBL] [Abstract][Full Text] [Related]
4. Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC Blazy C; Ellingrod V; Ward K Front Pharmacol; 2022; 13():939313. PubMed ID: 35814245 [TBL] [Abstract][Full Text] [Related]
5. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants. Bousman CA; Stevenson JM; Ramsey LB; Sangkuhl K; Hicks JK; Strawn JR; Singh AB; Ruaño G; Mueller DJ; Tsermpini EE; Brown JT; Bell GC; Leeder JS; Gaedigk A; Scott SA; Klein TE; Caudle KE; Bishop JR Clin Pharmacol Ther; 2023 Jul; 114(1):51-68. PubMed ID: 37032427 [TBL] [Abstract][Full Text] [Related]
6. Contrasting Kalla P; Namerow LB; Walker SA; Ruaño G; Malik S Pharmacogenomics; 2023 Feb; 24(3):131-139. PubMed ID: 36727491 [TBL] [Abstract][Full Text] [Related]
7. Clinical applications of CYP genotyping in psychiatry. Spina E; de Leon J J Neural Transm (Vienna); 2015 Jan; 122(1):5-28. PubMed ID: 25200585 [TBL] [Abstract][Full Text] [Related]
8. Trends in GP prescribing of psychotropic medications among young patients aged 16-24 years: a case study analysis. Brijnath B; Xia T; Turner L; Mazza D BMC Psychiatry; 2017 Jun; 17(1):214. PubMed ID: 28587610 [TBL] [Abstract][Full Text] [Related]
9. Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode. Pjevac M; Redenšek Trampuž S; Blagus T; Dolžan V; Bon J Front Psychiatry; 2023; 14():1250253. PubMed ID: 37608991 [TBL] [Abstract][Full Text] [Related]
10. [Use of antidepressant drugs in schizophrenic patients with depression]. Micallef J; Fakra E; Blin O Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628 [TBL] [Abstract][Full Text] [Related]
11. [Cytochrome pharmacogenetics applied to the prescription of antidepressants: Instructions for use]. Baldacci A; Saguin E; Annette S; Lahutte B; Colas MD; Delacour H Encephale; 2022 Aug; 48(4):462-471. PubMed ID: 35331467 [TBL] [Abstract][Full Text] [Related]
12. Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients. Jessel CD; Mostafa S; Potiriadis M; Everall IP; Gunn JM; Bousman CA Pharmacogenet Genomics; 2020 Sep; 30(7):145-152. PubMed ID: 32433340 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics. Quaranta S; Dupouey J; Colle R; Verstuyft C Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405 [TBL] [Abstract][Full Text] [Related]
14. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. de Leon J; Susce MT; Murray-Carmichael E Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacoresistance to psychotropic drugs in children and adolescents: Pharmacogenetic anomalies of cytochrome P450 2D6]. David A; Fernandez A; Menard ML; Dor E; Leali G; Maria F; Cruzel C; Askenazy F; Verstuyft C; Thümmler S Encephale; 2021 Jun; 47(3):227-234. PubMed ID: 33551122 [TBL] [Abstract][Full Text] [Related]
16. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
17. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. de Leon J; Armstrong SC; Cozza KL Psychosomatics; 2006; 47(1):75-85. PubMed ID: 16384813 [TBL] [Abstract][Full Text] [Related]
18. Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication. Walden LM; Brandl EJ; Tiwari AK; Cheema S; Freeman N; Braganza N; Kennedy JL; Müller DJ Psychiatry Res; 2019 Sep; 279():111-115. PubMed ID: 29699889 [TBL] [Abstract][Full Text] [Related]
19. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Zhou SF Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam. Veiga MI; Asimus S; Ferreira PE; Martins JP; Cavaco I; Ribeiro V; Hai TN; Petzold MG; Björkman A; Ashton M; Gil JP Eur J Clin Pharmacol; 2009 Apr; 65(4):355-63. PubMed ID: 18979093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]